Market Tracker

09/23 6:06am ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

77.40
Data as of Sep 22
 -0.37 / -0.48%
Today’s Change
47.03
Today|||52-Week Range
112.57
+20.37%
Year-to-Date

Today’s Trading

Previous close77.77
Today’s open77.89
Day’s range-- - --
Volume695,368
Average volume (3 months)684,657
Market cap$5.9B
Dividend yield--
Data as of 09/22/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-271.45%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book18.34

Competitors

 Today’s
change
Today’s
% change
CBSTCubist Pharmaceutica...-0.34-0.51%
ISISIsis Pharmaceuticals...-1.57-3.71%
QQuintiles Transnatio...-1.03-1.80%
ICLRICON PLC+0.42+0.75%
Data as of 09/22/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts